RACHEL RHODES: Open Payments
NPI 1598006876 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 9 payments from 7 companies in 2025. Trend: 2023 $161 · 2024 $259 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 2 | $51 |
| Astellas Pharma US Inc | 2 | $44 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Legend Biotech USA Inc. | 1 | $26 |
| Incyte Corporation | 1 | $26 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: clonoSEQ, Xospata, REBLOZYL, CARVYKTI, NIKTIMVO, XPOVIO, BREYANZI, REZUROCK.
Industry payments across TX — which companies pay providers there.
